Howe & Rusling Inc Novo Nordisk A S Transaction History

Howe & Rusling Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$103.24 - $121.81 $1,961 - $2,314	-19 Reduced 17.92%	87 $10,000
Q2 2021 Aug 13, 2021	SELL	$67.66 - $84.76 $67 - $84	-1 Reduced 0.93%	106 $9,000
Q1 2021 May 13, 2021	SELL	$67.06 - $75.82 $1,877 - $2,122	-28 Reduced 20.74%	107 $7,000
Q2 2020 Jul 15, 2020	SELL	$58.54 - $67.94 $2,868 - $3,329	-49 Reduced 26.63%	135 $9,000
Q1 2020 May 14, 2020	SELL	$49.46 - $64.78 $445 - $583	-9 Reduced 4.66%	184 $11,000
Q3 2019 Oct 31, 2019	SELL	$47.54 - $53.43 $3,708 - $4,167	-78 Reduced 28.78%	193 $10,000
Q2 2019 Aug 12, 2019	SELL	$46.79 - $52.47 $561 - $629	-12 Reduced 4.24%	271 $14,000
Q1 2019 Apr 29, 2019	BUY	$46.36 - $52.63 $4,543 - $5,157	98 Added 52.97%	283 $15,000
Q4 2018 Feb 04, 2019	SELL	$41.54 - $47.25 $1,287 - $1,464	-31 Reduced 14.35%	185 $9,000
Q4 2017 Jan 24, 2018	BUY	$47.53 - $53.73 $5,180 - $5,856	109 Added 101.87%	216 $12,000
Q3 2017 Oct 18, 2017	BUY	$41.15 - $49.22 $4,403 - $5,266	107	107 $5,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.